ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Gastroenterology

Top Gastroenterology Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL MURPHY MD

Gastroenterology

3,534

$202K

330
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 33%

$57
Average prescription price

Avg: $156

MARK MALLEK M.D.

Gastroenterology

1,155

$133K

162
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 33%

$115
Average prescription price

Avg: $156

DAVID FLAVIN MD

Gastroenterology

1,052

$195K

315
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$185
Average prescription price

Avg: $156

ROGER EPSTEIN M.D.

Gastroenterology

943

$189K

205
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 33%

$201
Average prescription price

Avg: $156

YUKI IGARI MD

Gastroenterology

835

$99.6K

279
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 33%

$119
Average prescription price

Avg: $156

WILLIAM MAHER M.D.

Gastroenterology

822

$80K

164
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 33%

$97
Average prescription price

Avg: $156

KNUT ROALSVIG MD

Gastroenterology

784

$117K

163
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 33%

$149
Average prescription price

Avg: $156

HOWARD MITZ D.O.

Gastroenterology

762

$194K

182
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 33%

$254
Average prescription price

Avg: $156

LYNN BUTTERLY M.D.

Gastroenterology

759

$13.7K

729
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 33%

$18
Average prescription price

Avg: $156

RAJA REHMAN M.D.

Gastroenterology

754

$69.4K

128
70 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 33%

$92
Average prescription price

Avg: $156

ALAIN ADES M.D.

Gastroenterology

725

$151K

178
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 33%

$208
Average prescription price

Avg: $156

ARISTOTLE DAMIANOS M.D.

Gastroenterology

691

$183K

212
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 33%

$264
Average prescription price

Avg: $156

BRIAN LACY PH.D; M.D

Gastroenterology

680

$151K

125
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 33%

$222
Average prescription price

Avg: $156

CHRISTOPHER DAINIAK M.D.

Gastroenterology

640

$93.9K

118
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 33%

$147
Average prescription price

Avg: $156

AYDAMIR ALRAKAWI M.D.

Gastroenterology

590

$116K

178
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 33%

$197
Average prescription price

Avg: $156

SCOTT OOSTERVEEN MD

Gastroenterology

577

$64K

153
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 33%

$111
Average prescription price

Avg: $156

MAURICE COHEN M.D.

Gastroenterology

567

$112K

104
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 33%

$198
Average prescription price

Avg: $156

STEVE BENSEN M.D.

Gastroenterology

546

$141K

66
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$257
Average prescription price

Avg: $156

JOHN DOWD D.O.

Gastroenterology

535

$89K

187
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 33%

$166
Average prescription price

Avg: $156

FRANCIS COLIZZO M.D.

Gastroenterology

513

$90.8K

132
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 33%

$177
Average prescription price

Avg: $156

MICHAEL KACZANOWSKI M.D.

Gastroenterology

487

$70.1K

129
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 33%

$144
Average prescription price

Avg: $156

OTTO TRINKL M.D.

Gastroenterology

485

$133K

79
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 33%

$274
Average prescription price

Avg: $156

STUART BROGADIR MD

Gastroenterology

478

$146K

83
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 33%

$306
Average prescription price

Avg: $156

STACY PRALL D.O.

Gastroenterology

469

$74K

67
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 33%

$158
Average prescription price

Avg: $156

ARIFA TOOR MD

Gastroenterology

469

$62.5K

79
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 33%

$133
Average prescription price

Avg: $156

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank